Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MAZ
|
ENSG00000103495.9 | MYC associated zinc finger protein |
ZNF281
|
ENSG00000162702.7 | zinc finger protein 281 |
GTF2F1
|
ENSG00000125651.9 | general transcription factor IIF subunit 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GTF2F1 | hg19_v2_chr19_-_6393216_6393229 | 0.22 | 2.4e-01 | Click! |
MAZ | hg19_v2_chr16_+_29819096_29819250 | -0.18 | 3.5e-01 | Click! |
ZNF281 | hg19_v2_chr1_-_200379104_200379128, hg19_v2_chr1_-_200379129_200379174 | 0.11 | 5.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_51471381 | 4.84 |
ENST00000594641.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr1_-_205419053 | 4.69 |
ENST00000367154.1
|
LEMD1
|
LEM domain containing 1 |
chr19_+_35645618 | 4.54 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr19_-_51471362 | 4.40 |
ENST00000376853.4
ENST00000424910.2 |
KLK6
|
kallikrein-related peptidase 6 |
chr19_-_51487071 | 4.32 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
chr19_-_49015050 | 4.23 |
ENST00000600059.1
|
LMTK3
|
lemur tyrosine kinase 3 |
chr19_+_35645817 | 4.04 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr19_-_51456344 | 3.93 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
chr17_+_70117153 | 3.77 |
ENST00000245479.2
|
SOX9
|
SRY (sex determining region Y)-box 9 |
chr7_-_41740181 | 3.70 |
ENST00000442711.1
|
INHBA
|
inhibin, beta A |
chr1_-_20812690 | 3.59 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr19_-_42573650 | 3.54 |
ENST00000593562.1
|
GRIK5
|
glutamate receptor, ionotropic, kainate 5 |
chr12_+_4382917 | 3.43 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
chr19_-_51456321 | 3.32 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
chr2_-_216300784 | 3.05 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
chr19_-_51487282 | 2.99 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
chr19_-_51504852 | 2.91 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
chr12_+_53491220 | 2.81 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
chr2_-_72375167 | 2.81 |
ENST00000001146.2
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1 |
chr1_-_17307173 | 2.79 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
chr19_-_51456198 | 2.70 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
chr19_-_55658281 | 2.62 |
ENST00000585321.2
ENST00000587465.2 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr19_-_55660561 | 2.58 |
ENST00000587758.1
ENST00000356783.5 ENST00000291901.8 ENST00000588426.1 ENST00000588147.1 ENST00000536926.1 ENST00000588981.1 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr3_-_98620500 | 2.56 |
ENST00000326840.6
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2 |
chr14_-_94595993 | 2.48 |
ENST00000238609.3
|
IFI27L2
|
interferon, alpha-inducible protein 27-like 2 |
chr7_-_102252038 | 2.41 |
ENST00000461209.1
|
RASA4
|
RAS p21 protein activator 4 |
chr22_+_38071615 | 2.34 |
ENST00000215909.5
|
LGALS1
|
lectin, galactoside-binding, soluble, 1 |
chr2_+_45168875 | 2.33 |
ENST00000260653.3
|
SIX3
|
SIX homeobox 3 |
chr17_-_58469474 | 2.29 |
ENST00000300896.4
|
USP32
|
ubiquitin specific peptidase 32 |
chr7_+_145813453 | 2.26 |
ENST00000361727.3
|
CNTNAP2
|
contactin associated protein-like 2 |
chr8_+_22022800 | 2.22 |
ENST00000397814.3
|
BMP1
|
bone morphogenetic protein 1 |
chr7_-_23510086 | 2.21 |
ENST00000258729.3
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3 |
chr17_-_58469591 | 2.16 |
ENST00000589335.1
|
USP32
|
ubiquitin specific peptidase 32 |
chr19_-_51472031 | 2.16 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr10_+_17270214 | 2.14 |
ENST00000544301.1
|
VIM
|
vimentin |
chr19_-_19051927 | 2.12 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
chr7_-_143059780 | 2.11 |
ENST00000409578.1
ENST00000409346.1 |
FAM131B
|
family with sequence similarity 131, member B |
chr17_-_58469687 | 2.11 |
ENST00000590133.1
|
USP32
|
ubiquitin specific peptidase 32 |
chr1_-_28503693 | 2.08 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
chrX_-_152486108 | 2.07 |
ENST00000356661.5
|
MAGEA1
|
melanoma antigen family A, 1 (directs expression of antigen MZ2-E) |
chr6_-_30654977 | 2.03 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
chr17_-_7155274 | 2.03 |
ENST00000318988.6
ENST00000575783.1 ENST00000573600.1 |
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
chr10_+_88718314 | 2.01 |
ENST00000348795.4
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
chr2_+_79740118 | 1.99 |
ENST00000496558.1
ENST00000451966.1 |
CTNNA2
|
catenin (cadherin-associated protein), alpha 2 |
chr16_-_84651673 | 1.94 |
ENST00000262428.4
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
chr14_+_24540731 | 1.94 |
ENST00000558859.1
ENST00000559197.1 ENST00000560828.1 ENST00000216775.2 ENST00000560884.1 |
CPNE6
|
copine VI (neuronal) |
chr19_-_51568324 | 1.92 |
ENST00000595547.1
ENST00000335422.3 ENST00000595793.1 ENST00000596955.1 |
KLK13
|
kallikrein-related peptidase 13 |
chr1_+_211432700 | 1.92 |
ENST00000452621.2
|
RCOR3
|
REST corepressor 3 |
chr12_+_56415100 | 1.92 |
ENST00000547791.1
|
IKZF4
|
IKAROS family zinc finger 4 (Eos) |
chr20_-_62103862 | 1.92 |
ENST00000344462.4
ENST00000357249.2 ENST00000359125.2 ENST00000360480.3 ENST00000370224.1 ENST00000344425.5 ENST00000354587.3 ENST00000359689.1 |
KCNQ2
|
potassium voltage-gated channel, KQT-like subfamily, member 2 |
chr5_-_157002775 | 1.90 |
ENST00000257527.4
|
ADAM19
|
ADAM metallopeptidase domain 19 |
chr12_+_57522258 | 1.88 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr19_+_44037546 | 1.84 |
ENST00000601282.1
|
ZNF575
|
zinc finger protein 575 |
chr12_+_4385230 | 1.82 |
ENST00000536537.1
|
CCND2
|
cyclin D2 |
chr19_+_56652556 | 1.81 |
ENST00000337080.3
|
ZNF444
|
zinc finger protein 444 |
chr1_-_244013384 | 1.79 |
ENST00000366539.1
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3 |
chr20_-_44540686 | 1.78 |
ENST00000477313.1
ENST00000542937.1 ENST00000372431.3 ENST00000354050.4 ENST00000420868.2 |
PLTP
|
phospholipid transfer protein |
chr12_+_56915776 | 1.77 |
ENST00000550726.1
ENST00000542360.1 |
RBMS2
|
RNA binding motif, single stranded interacting protein 2 |
chr9_+_128509624 | 1.76 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
chr16_-_84651647 | 1.75 |
ENST00000564057.1
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
chrX_-_107019181 | 1.74 |
ENST00000315660.4
ENST00000372384.2 ENST00000502650.1 ENST00000506724.1 |
TSC22D3
|
TSC22 domain family, member 3 |
chr17_+_60704762 | 1.72 |
ENST00000303375.5
|
MRC2
|
mannose receptor, C type 2 |
chr7_-_143059845 | 1.72 |
ENST00000443739.2
|
FAM131B
|
family with sequence similarity 131, member B |
chr2_+_30454390 | 1.71 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
chr12_+_57853918 | 1.69 |
ENST00000532291.1
ENST00000543426.1 ENST00000228682.2 ENST00000546141.1 |
GLI1
|
GLI family zinc finger 1 |
chr4_+_7194247 | 1.68 |
ENST00000507866.2
|
SORCS2
|
sortilin-related VPS10 domain containing receptor 2 |
chr6_-_48036363 | 1.67 |
ENST00000543600.1
ENST00000398738.2 ENST00000339488.4 |
PTCHD4
|
patched domain containing 4 |
chr19_-_51472222 | 1.66 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
chr1_-_40157345 | 1.65 |
ENST00000372844.3
|
HPCAL4
|
hippocalcin like 4 |
chr1_-_93426998 | 1.65 |
ENST00000370310.4
|
FAM69A
|
family with sequence similarity 69, member A |
chr22_-_43583079 | 1.64 |
ENST00000216129.6
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
chr17_+_4736627 | 1.63 |
ENST00000355280.6
ENST00000347992.7 |
MINK1
|
misshapen-like kinase 1 |
chr18_+_56530136 | 1.63 |
ENST00000591083.1
|
ZNF532
|
zinc finger protein 532 |
chr12_+_56414851 | 1.63 |
ENST00000547167.1
|
IKZF4
|
IKAROS family zinc finger 4 (Eos) |
chr11_+_5617858 | 1.62 |
ENST00000380097.3
|
TRIM6
|
tripartite motif containing 6 |
chr12_+_56915713 | 1.61 |
ENST00000262031.5
ENST00000552247.2 |
RBMS2
|
RNA binding motif, single stranded interacting protein 2 |
chr19_-_51222707 | 1.61 |
ENST00000391814.1
|
SHANK1
|
SH3 and multiple ankyrin repeat domains 1 |
chr7_-_27135591 | 1.61 |
ENST00000343060.4
ENST00000355633.5 |
HOXA1
|
homeobox A1 |
chr11_-_123065989 | 1.60 |
ENST00000448775.2
|
CLMP
|
CXADR-like membrane protein |
chr2_+_27193480 | 1.58 |
ENST00000233121.2
ENST00000405074.3 |
MAPRE3
|
microtubule-associated protein, RP/EB family, member 3 |
chr19_+_38826477 | 1.57 |
ENST00000409410.2
ENST00000215069.4 |
CATSPERG
|
catsper channel auxiliary subunit gamma |
chr11_+_126225789 | 1.56 |
ENST00000530591.1
ENST00000534083.1 |
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
chr1_+_182992545 | 1.56 |
ENST00000258341.4
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2) |
chrX_-_107018969 | 1.55 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
chr3_+_154797428 | 1.53 |
ENST00000460393.1
|
MME
|
membrane metallo-endopeptidase |
chr19_-_19051993 | 1.53 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
chr8_+_7752151 | 1.53 |
ENST00000302247.2
|
DEFB4A
|
defensin, beta 4A |
chr17_-_76628125 | 1.52 |
ENST00000586185.1
ENST00000591384.1 |
CTD-2357A8.3
|
CTD-2357A8.3 |
chr7_-_28220354 | 1.52 |
ENST00000283928.5
|
JAZF1
|
JAZF zinc finger 1 |
chr9_+_128509663 | 1.51 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
chr2_+_5832799 | 1.51 |
ENST00000322002.3
|
SOX11
|
SRY (sex determining region Y)-box 11 |
chr3_-_13921594 | 1.51 |
ENST00000285018.4
|
WNT7A
|
wingless-type MMTV integration site family, member 7A |
chr20_+_3776936 | 1.50 |
ENST00000439880.2
|
CDC25B
|
cell division cycle 25B |
chr10_+_88718397 | 1.50 |
ENST00000372017.3
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
chr11_+_5617330 | 1.50 |
ENST00000278302.5
ENST00000424369.1 ENST00000507320.1 ENST00000380107.1 |
TRIM6
|
tripartite motif containing 6 |
chr11_-_111783595 | 1.50 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
chr10_+_99473455 | 1.50 |
ENST00000285605.6
|
MARVELD1
|
MARVEL domain containing 1 |
chr10_-_100995540 | 1.48 |
ENST00000370546.1
ENST00000404542.1 |
HPSE2
|
heparanase 2 |
chr19_-_55658687 | 1.48 |
ENST00000593046.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr2_-_208030647 | 1.48 |
ENST00000309446.6
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
chr1_-_155948218 | 1.48 |
ENST00000313667.4
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2 |
chr15_+_63334831 | 1.47 |
ENST00000288398.6
ENST00000358278.3 ENST00000560445.1 ENST00000403994.3 ENST00000357980.4 ENST00000559556.1 ENST00000559397.1 ENST00000267996.7 ENST00000560970.1 |
TPM1
|
tropomyosin 1 (alpha) |
chr10_-_103603523 | 1.47 |
ENST00000370046.1
|
KCNIP2
|
Kv channel interacting protein 2 |
chr11_-_2158507 | 1.45 |
ENST00000381392.1
ENST00000381395.1 ENST00000418738.2 |
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr11_-_2906979 | 1.44 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr14_+_24867992 | 1.43 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr8_+_22022653 | 1.41 |
ENST00000354870.5
ENST00000397816.3 ENST00000306349.8 |
BMP1
|
bone morphogenetic protein 1 |
chr7_+_100770328 | 1.39 |
ENST00000223095.4
ENST00000445463.2 |
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
chr2_-_165477971 | 1.39 |
ENST00000446413.2
|
GRB14
|
growth factor receptor-bound protein 14 |
chr9_+_34989638 | 1.38 |
ENST00000453597.3
ENST00000335998.3 ENST00000312316.5 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr8_-_60031762 | 1.37 |
ENST00000361421.1
|
TOX
|
thymocyte selection-associated high mobility group box |
chr8_-_23261589 | 1.37 |
ENST00000524168.1
ENST00000523833.2 ENST00000519243.1 ENST00000389131.3 |
LOXL2
|
lysyl oxidase-like 2 |
chr12_-_131200810 | 1.36 |
ENST00000536002.1
ENST00000544034.1 |
RIMBP2
RP11-662M24.2
|
RIMS binding protein 2 RP11-662M24.2 |
chr5_-_127873659 | 1.35 |
ENST00000262464.4
|
FBN2
|
fibrillin 2 |
chr19_-_14629224 | 1.35 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
chr2_-_241396131 | 1.35 |
ENST00000404327.3
|
AC110619.2
|
Uncharacterized protein |
chr10_+_102505468 | 1.34 |
ENST00000361791.3
ENST00000355243.3 ENST00000428433.1 ENST00000370296.2 |
PAX2
|
paired box 2 |
chr4_-_153700864 | 1.33 |
ENST00000304337.2
|
TIGD4
|
tigger transposable element derived 4 |
chrX_+_41192595 | 1.33 |
ENST00000399959.2
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked |
chr11_+_5617976 | 1.33 |
ENST00000445329.1
|
TRIM6
|
tripartite motif containing 6 |
chr17_-_7154984 | 1.33 |
ENST00000574322.1
|
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
chr4_+_191001979 | 1.32 |
ENST00000538692.1
|
DUX4L4
|
double homeobox 4 like 4 |
chr5_+_133861339 | 1.32 |
ENST00000282605.4
ENST00000361895.2 ENST00000402835.1 |
PHF15
|
jade family PHD finger 2 |
chr5_-_171881362 | 1.32 |
ENST00000519643.1
|
SH3PXD2B
|
SH3 and PX domains 2B |
chrX_-_48325857 | 1.31 |
ENST00000376875.1
|
SLC38A5
|
solute carrier family 38, member 5 |
chr11_+_57365150 | 1.31 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr16_+_55512742 | 1.30 |
ENST00000568715.1
ENST00000219070.4 |
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chr5_-_157002749 | 1.30 |
ENST00000517905.1
ENST00000430702.2 ENST00000394020.1 |
ADAM19
|
ADAM metallopeptidase domain 19 |
chr12_-_54813229 | 1.29 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
chr4_+_191002273 | 1.28 |
ENST00000604656.1
ENST00000554637.2 |
DUX4L4
|
double homeobox 4 like 4 |
chr11_+_86748998 | 1.27 |
ENST00000525018.1
ENST00000355734.4 |
TMEM135
|
transmembrane protein 135 |
chr16_+_2802623 | 1.26 |
ENST00000576924.1
ENST00000575009.1 ENST00000576415.1 ENST00000571378.1 |
SRRM2
|
serine/arginine repetitive matrix 2 |
chrX_-_119695279 | 1.26 |
ENST00000336592.6
|
CUL4B
|
cullin 4B |
chr14_+_74815116 | 1.26 |
ENST00000256362.4
|
VRTN
|
vertebrae development associated |
chr16_+_88923494 | 1.26 |
ENST00000567895.1
ENST00000301021.3 ENST00000565504.1 ENST00000567312.1 ENST00000568583.1 ENST00000561840.1 |
TRAPPC2L
|
trafficking protein particle complex 2-like |
chr19_-_19051103 | 1.26 |
ENST00000542541.2
ENST00000433218.2 |
HOMER3
|
homer homolog 3 (Drosophila) |
chr16_-_29479154 | 1.25 |
ENST00000549950.1
|
RP11-345J4.3
|
Uncharacterized protein |
chr19_+_41725088 | 1.24 |
ENST00000301178.4
|
AXL
|
AXL receptor tyrosine kinase |
chr10_+_120967072 | 1.24 |
ENST00000392870.2
|
GRK5
|
G protein-coupled receptor kinase 5 |
chr9_+_78505554 | 1.24 |
ENST00000545128.1
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5 |
chr17_+_7211280 | 1.23 |
ENST00000419711.2
ENST00000571955.1 ENST00000573714.1 |
EIF5A
|
eukaryotic translation initiation factor 5A |
chr9_-_33167308 | 1.23 |
ENST00000535206.1
ENST00000379731.4 |
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
chr19_-_51466681 | 1.22 |
ENST00000456750.2
|
KLK6
|
kallikrein-related peptidase 6 |
chr12_-_54785054 | 1.22 |
ENST00000352268.6
ENST00000549962.1 |
ZNF385A
|
zinc finger protein 385A |
chr11_-_2160611 | 1.22 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr2_+_204193149 | 1.22 |
ENST00000422511.2
|
ABI2
|
abl-interactor 2 |
chr10_-_103599591 | 1.22 |
ENST00000348850.5
|
KCNIP2
|
Kv channel interacting protein 2 |
chr15_-_74495188 | 1.21 |
ENST00000563965.1
ENST00000395105.4 |
STRA6
|
stimulated by retinoic acid 6 |
chr7_-_150780487 | 1.21 |
ENST00000482202.1
|
TMUB1
|
transmembrane and ubiquitin-like domain containing 1 |
chr19_-_49864746 | 1.21 |
ENST00000598810.1
|
TEAD2
|
TEA domain family member 2 |
chr8_+_95653427 | 1.20 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
chr9_-_35691017 | 1.20 |
ENST00000378292.3
|
TPM2
|
tropomyosin 2 (beta) |
chr8_+_30241934 | 1.20 |
ENST00000538486.1
|
RBPMS
|
RNA binding protein with multiple splicing |
chrX_-_54384425 | 1.20 |
ENST00000375169.3
ENST00000354646.2 |
WNK3
|
WNK lysine deficient protein kinase 3 |
chr10_+_102891048 | 1.20 |
ENST00000467928.2
|
TLX1
|
T-cell leukemia homeobox 1 |
chr18_-_31803169 | 1.19 |
ENST00000590712.1
|
NOL4
|
nucleolar protein 4 |
chr12_+_107168342 | 1.19 |
ENST00000392837.4
|
RIC8B
|
RIC8 guanine nucleotide exchange factor B |
chr20_+_306177 | 1.18 |
ENST00000544632.1
|
SOX12
|
SRY (sex determining region Y)-box 12 |
chr6_-_32119877 | 1.18 |
ENST00000375152.2
|
PRRT1
|
proline-rich transmembrane protein 1 |
chr3_+_154797877 | 1.18 |
ENST00000462745.1
ENST00000493237.1 |
MME
|
membrane metallo-endopeptidase |
chr11_-_64410787 | 1.18 |
ENST00000301894.2
|
NRXN2
|
neurexin 2 |
chr6_-_41863098 | 1.18 |
ENST00000373006.1
|
USP49
|
ubiquitin specific peptidase 49 |
chr2_+_210288760 | 1.17 |
ENST00000199940.6
|
MAP2
|
microtubule-associated protein 2 |
chr8_+_80523962 | 1.16 |
ENST00000518491.1
|
STMN2
|
stathmin-like 2 |
chr19_-_35625765 | 1.16 |
ENST00000591633.1
|
LGI4
|
leucine-rich repeat LGI family, member 4 |
chr17_+_7210921 | 1.16 |
ENST00000573542.1
|
EIF5A
|
eukaryotic translation initiation factor 5A |
chr6_-_10412600 | 1.16 |
ENST00000379608.3
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chrX_+_48367338 | 1.16 |
ENST00000359882.4
ENST00000537758.1 ENST00000367574.4 ENST00000355961.4 ENST00000489940.1 ENST00000361988.3 |
PORCN
|
porcupine homolog (Drosophila) |
chr2_-_74781061 | 1.16 |
ENST00000264094.3
ENST00000393937.2 ENST00000409986.1 |
LOXL3
|
lysyl oxidase-like 3 |
chr13_-_44361025 | 1.15 |
ENST00000261488.6
|
ENOX1
|
ecto-NOX disulfide-thiol exchanger 1 |
chr1_-_204121102 | 1.15 |
ENST00000367202.4
|
ETNK2
|
ethanolamine kinase 2 |
chr3_-_195538760 | 1.15 |
ENST00000475231.1
|
MUC4
|
mucin 4, cell surface associated |
chr19_-_8675559 | 1.15 |
ENST00000597188.1
|
ADAMTS10
|
ADAM metallopeptidase with thrombospondin type 1 motif, 10 |
chr17_-_7120498 | 1.15 |
ENST00000485100.1
|
DLG4
|
discs, large homolog 4 (Drosophila) |
chr18_+_49866496 | 1.15 |
ENST00000442544.2
|
DCC
|
deleted in colorectal carcinoma |
chr14_-_24047965 | 1.14 |
ENST00000397118.3
ENST00000356300.4 |
JPH4
|
junctophilin 4 |
chr12_-_48152428 | 1.14 |
ENST00000449771.2
ENST00000395358.3 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr9_-_34589734 | 1.14 |
ENST00000378980.3
|
CNTFR
|
ciliary neurotrophic factor receptor |
chr15_-_72612470 | 1.14 |
ENST00000287202.5
|
CELF6
|
CUGBP, Elav-like family member 6 |
chr22_-_37584321 | 1.14 |
ENST00000397110.2
ENST00000337843.2 |
C1QTNF6
|
C1q and tumor necrosis factor related protein 6 |
chr11_-_59436453 | 1.14 |
ENST00000300146.9
|
PATL1
|
protein associated with topoisomerase II homolog 1 (yeast) |
chr11_+_69455855 | 1.12 |
ENST00000227507.2
ENST00000536559.1 |
CCND1
|
cyclin D1 |
chr6_-_131384373 | 1.12 |
ENST00000392427.3
ENST00000525271.1 ENST00000527411.1 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
chr9_+_34990219 | 1.11 |
ENST00000541010.1
ENST00000454002.2 ENST00000545841.1 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr19_+_42212501 | 1.11 |
ENST00000398599.4
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5 |
chr1_+_180199393 | 1.11 |
ENST00000263726.2
|
LHX4
|
LIM homeobox 4 |
chr19_+_42212526 | 1.10 |
ENST00000598976.1
ENST00000435837.2 ENST00000221992.6 ENST00000405816.1 |
CEA
CEACAM5
|
Uncharacterized protein carcinoembryonic antigen-related cell adhesion molecule 5 |
chr7_+_100797678 | 1.10 |
ENST00000337619.5
|
AP1S1
|
adaptor-related protein complex 1, sigma 1 subunit |
chr13_+_28712614 | 1.10 |
ENST00000380958.3
|
PAN3
|
PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) |
chr11_-_2160180 | 1.09 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chrX_+_70503037 | 1.09 |
ENST00000535149.1
|
NONO
|
non-POU domain containing, octamer-binding |
chr10_-_75410771 | 1.09 |
ENST00000372873.4
|
SYNPO2L
|
synaptopodin 2-like |
chr15_-_59041768 | 1.09 |
ENST00000402627.1
ENST00000396140.2 ENST00000559053.1 ENST00000561288.1 |
ADAM10
|
ADAM metallopeptidase domain 10 |
chr20_-_31124186 | 1.08 |
ENST00000375678.3
|
C20orf112
|
chromosome 20 open reading frame 112 |
chr19_-_14049184 | 1.08 |
ENST00000339560.5
|
PODNL1
|
podocan-like 1 |
chr19_-_51472823 | 1.08 |
ENST00000310157.2
|
KLK6
|
kallikrein-related peptidase 6 |
chr19_+_35759824 | 1.08 |
ENST00000343550.5
|
USF2
|
upstream transcription factor 2, c-fos interacting |
chr9_+_126118449 | 1.07 |
ENST00000359999.3
ENST00000373631.3 |
CRB2
|
crumbs homolog 2 (Drosophila) |
chr21_+_40177755 | 1.07 |
ENST00000360938.3
ENST00000432278.1 |
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
chr21_-_28217721 | 1.07 |
ENST00000284984.3
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 17.2 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
2.8 | 8.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
1.4 | 4.1 | GO:0060516 | primary prostatic bud elongation(GO:0060516) |
1.3 | 3.9 | GO:0035981 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
1.1 | 3.4 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
1.1 | 5.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.0 | 3.1 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
1.0 | 5.1 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
1.0 | 2.9 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.9 | 0.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.9 | 2.6 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
0.8 | 7.6 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.8 | 3.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.8 | 1.5 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.7 | 2.2 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.7 | 15.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.7 | 2.1 | GO:1904301 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.7 | 2.7 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.7 | 3.3 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.6 | 3.2 | GO:0070384 | Harderian gland development(GO:0070384) |
0.6 | 1.9 | GO:0050894 | determination of affect(GO:0050894) |
0.6 | 3.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.6 | 1.8 | GO:0033241 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.6 | 3.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.6 | 1.8 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.6 | 5.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 2.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.5 | 4.4 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.5 | 1.6 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.5 | 2.7 | GO:0048749 | compound eye development(GO:0048749) |
0.5 | 4.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 1.6 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.5 | 3.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.5 | 1.5 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.5 | 1.5 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.5 | 2.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.5 | 3.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 0.5 | GO:0051885 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) positive regulation of anagen(GO:0051885) |
0.5 | 2.0 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.5 | 2.0 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
0.5 | 1.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.5 | 1.0 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
0.5 | 2.4 | GO:0061552 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.5 | 2.3 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.5 | 1.8 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.5 | 0.9 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.5 | 1.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.4 | 1.8 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
0.4 | 1.3 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.4 | 1.7 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.4 | 1.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 0.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.4 | 1.3 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.4 | 2.5 | GO:0030421 | defecation(GO:0030421) |
0.4 | 1.2 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.4 | 0.4 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.4 | 1.2 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.4 | 0.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.4 | 1.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.4 | 1.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.4 | 1.6 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.4 | 2.0 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.4 | 0.4 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.4 | 0.4 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.4 | 3.6 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.4 | 1.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.4 | 3.9 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.4 | 10.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 0.4 | GO:1903201 | cell death in response to oxidative stress(GO:0036473) neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced cell death(GO:1903201) regulation of oxidative stress-induced neuron death(GO:1903203) negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.4 | 4.7 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.4 | 1.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 0.4 | GO:0060290 | transdifferentiation(GO:0060290) |
0.4 | 1.1 | GO:0061114 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.4 | 1.1 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.4 | 1.1 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.4 | 4.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.4 | 1.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 1.9 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.4 | 1.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.4 | 2.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 1.5 | GO:0031049 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
0.4 | 1.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.4 | 1.4 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.4 | 0.4 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.4 | 4.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.4 | 2.1 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.4 | 1.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.4 | 0.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.3 | 1.0 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.3 | 2.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 2.8 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.3 | 1.0 | GO:0038189 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
0.3 | 0.3 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.3 | 1.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 1.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 1.4 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.3 | 1.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 1.4 | GO:2000724 | positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.3 | 4.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 1.0 | GO:0032499 | detection of peptidoglycan(GO:0032499) |
0.3 | 0.6 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.3 | 1.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 0.6 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) |
0.3 | 1.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.3 | 1.9 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.3 | 0.9 | GO:0048627 | myoblast development(GO:0048627) |
0.3 | 2.4 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
0.3 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.3 | 1.5 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.3 | 0.3 | GO:0035412 | regulation of catenin import into nucleus(GO:0035412) |
0.3 | 0.6 | GO:0003166 | bundle of His development(GO:0003166) |
0.3 | 1.2 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.3 | 1.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.3 | 1.2 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.3 | 3.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 4.4 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.3 | 2.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.3 | 0.9 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.3 | 0.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 1.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.3 | 0.8 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.3 | 1.7 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 0.3 | GO:0060157 | urinary bladder development(GO:0060157) |
0.3 | 1.9 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.3 | 1.9 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.3 | 0.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.3 | 1.1 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
0.3 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 1.6 | GO:0051012 | microtubule sliding(GO:0051012) |
0.3 | 2.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 1.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.3 | 1.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 0.8 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
0.3 | 1.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 2.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 5.5 | GO:0001502 | cartilage condensation(GO:0001502) |
0.3 | 0.5 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.3 | 4.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.3 | 0.8 | GO:0021503 | neural fold bending(GO:0021503) |
0.3 | 1.5 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.2 | 0.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.7 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.2 | 0.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 1.0 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.2 | 1.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 2.7 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.7 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.2 | 0.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 3.6 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.2 | 1.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 0.2 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.2 | 1.9 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.2 | 0.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.2 | 0.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.2 | 0.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 0.9 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.2 | 0.9 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.2 | 1.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.7 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.2 | 0.7 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.2 | 0.5 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.2 | 0.9 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.2 | 1.1 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 1.4 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.2 | 0.9 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.2 | 0.4 | GO:0098722 | asymmetric stem cell division(GO:0098722) |
0.2 | 0.9 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.2 | 1.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 1.1 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
0.2 | 0.2 | GO:0007369 | gastrulation(GO:0007369) |
0.2 | 1.3 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.2 | 0.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.4 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.2 | 0.9 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.2 | 0.2 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 0.9 | GO:0036269 | swimming behavior(GO:0036269) |
0.2 | 1.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 8.1 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 0.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 0.2 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.6 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 0.2 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) L-glutamate import(GO:0051938) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.2 | 3.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 1.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.4 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.2 | 0.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 0.4 | GO:0097187 | dentinogenesis(GO:0097187) |
0.2 | 1.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 0.6 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.2 | 0.4 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.2 | 0.8 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.2 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 1.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.4 | GO:0031247 | actin rod assembly(GO:0031247) |
0.2 | 0.6 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.2 | 0.4 | GO:0003192 | mitral valve formation(GO:0003192) |
0.2 | 0.8 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.2 | 0.2 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.2 | 1.6 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.2 | 1.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.6 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 1.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 1.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 1.0 | GO:1990834 | response to odorant(GO:1990834) |
0.2 | 0.4 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.2 | 0.6 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.2 | 5.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 3.4 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.2 | 1.9 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 0.2 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.2 | 1.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.2 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.2 | 0.4 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.2 | 1.1 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.2 | 0.6 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.2 | 1.9 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.2 | 0.8 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.2 | 0.2 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.2 | 0.4 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 0.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.2 | 0.9 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 3.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.2 | GO:0036491 | regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) regulation of PERK-mediated unfolded protein response(GO:1903897) negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 2.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.2 | 0.9 | GO:1904640 | response to methionine(GO:1904640) |
0.2 | 0.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 0.6 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.2 | 0.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 0.6 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.2 | 0.2 | GO:0051896 | regulation of protein kinase B signaling(GO:0051896) |
0.2 | 0.5 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
0.2 | 2.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.2 | 0.5 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 1.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 0.5 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.2 | 0.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 1.6 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 1.1 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.2 | 0.5 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.2 | 1.1 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
0.2 | 0.7 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.2 | 1.6 | GO:0046958 | nonassociative learning(GO:0046958) |
0.2 | 1.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.2 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.2 | 0.9 | GO:0072679 | thymocyte migration(GO:0072679) |
0.2 | 1.6 | GO:0048511 | rhythmic process(GO:0048511) |
0.2 | 1.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.2 | 1.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 1.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.3 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.2 | 1.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.2 | 0.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 0.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 1.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.2 | 0.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 1.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 1.2 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.2 | 0.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.2 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.2 | 0.7 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 3.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 2.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 1.8 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 0.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.3 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.2 | 0.5 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.2 | 1.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.5 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 0.6 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.2 | 0.5 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.2 | 0.5 | GO:0060426 | lung vasculature development(GO:0060426) |
0.2 | 0.2 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.2 | 1.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 2.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 4.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.5 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.2 | 0.5 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.2 | 1.6 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 0.9 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.2 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.8 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.2 | 0.5 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 0.2 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.2 | 3.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 0.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.2 | 0.8 | GO:0060356 | leucine import(GO:0060356) |
0.2 | 0.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 1.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 1.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.8 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 1.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.2 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.2 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 1.8 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 0.3 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 0.8 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.1 | 11.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.1 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.1 | 7.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.1 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.1 | 0.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.6 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 2.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.6 | GO:0044467 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
0.1 | 0.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.4 | GO:0090210 | detection of temperature stimulus involved in thermoception(GO:0050960) regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) response to capsazepine(GO:1901594) |
0.1 | 0.4 | GO:1904603 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.1 | 6.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.4 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.1 | 1.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 1.0 | GO:0048565 | digestive tract development(GO:0048565) |
0.1 | 0.1 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.1 | 1.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.7 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 3.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0021626 | hindbrain maturation(GO:0021578) pons maturation(GO:0021586) central nervous system maturation(GO:0021626) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.1 | 0.3 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
0.1 | 0.6 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.1 | 0.1 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.1 | 0.4 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.1 | 1.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 0.4 | GO:0003095 | pressure natriuresis(GO:0003095) |
0.1 | 1.3 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 1.3 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.1 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 1.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.6 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 1.0 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.1 | 1.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.1 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 1.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 1.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.4 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.3 | GO:0003285 | septum secundum development(GO:0003285) |
0.1 | 0.7 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.3 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.1 | 1.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 1.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.4 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.1 | 1.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.3 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.9 | GO:0090287 | regulation of cellular response to growth factor stimulus(GO:0090287) |
0.1 | 3.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.4 | GO:0035623 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
0.1 | 0.8 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.1 | 0.1 | GO:2000793 | cell proliferation involved in heart valve development(GO:2000793) |
0.1 | 1.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.4 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.1 | 0.3 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.1 | 1.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.5 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.1 | 0.1 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.1 | 0.1 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.1 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.1 | 0.8 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 2.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.5 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
0.1 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 1.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.5 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.1 | 1.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.4 | GO:0043405 | regulation of MAP kinase activity(GO:0043405) |
0.1 | 0.1 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.1 | 0.1 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.1 | 0.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 2.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.2 | GO:0075528 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.1 | 0.6 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.8 | GO:0070561 |